Purpose: As health care progresses toward pay for performance reimbursement models and focus is placed on the patient as a consumer, health care systems must adapt by initiating new programs and services. This institution responded by implementing a “Meds 2 Beds” program integrating clinical services with dispensing and medication delivery during transitions of care. This study evaluates outcomes relevant to patients, health care providers, pharmacists, and administrators. Methods: This observational chart review evaluated the effectiveness of a “Meds 2 Beds” program from May 1, 2014, through December 1, 2015. Patients who participated in this program were matched 1:1 with controls who did not. The primary outcome was 30-day hospital readmission. Secondary outcomes included 30-day emergency department (ED) visits, patient satisfaction, and financial impact. Results: In this sample, 185 “Meds 2 Beds” patients were matched to 185 controls. Thirty day readmission occurred in 16 (8.7%) “Meds 2 Beds” cases and 19 (10.3%) controls (P = .71). Rates of 30-day ED visits were nonsignificantly reduced in cases (22 [11.9%] vs 33 [18.1%]; odds ratio = 0.62, P = .11) and occurred significantly later (11 vs 7 days, P = .03). Conclusions: This study showcases a creative medication delivery and discharge counseling program. The program provides financial benefit to the institution creating a direct revenue stream from prescription dispensing while highlighting a potential for reduced readmissions and ED visits (although a statistically significant difference was not demonstrated in this analysis). A similar model can be adopted by other health care institutions to improve the quality of patient care.
ForsterAJMurffHJPetersonJFGandhiTKBatesDW.Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20(4):317-323.
2.
SchnipperJLKirwinJLCotugnoMC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565-571.
3.
KripalaniSPriceMVigilVEpsteinKR.Frequency and predictors of prescription-related issues after hospital discharge. J Hosp Med. 2008;3(1):12-19.
4.
KripalaniSHendersonLEJacobsonTAVaccarinoV.Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008.
May;83(5):529-35.
5.
Summary of HCAHPS Survey Results. Hcahpsonline.org/HCAHPS_Executive_Insight. Baltimore, MD: Centers for Medicare & Medicaid Services; 2015.
6.
StillKLDavisAKChilipkoAAJenkosolANorwoodDK.Evaluation of a pharmacy-driven inpatient discharge counseling service: impact on 30-day readmission rates. Consult Pharm. 2013;28(12):775-785.
7.
BallingLErstadBLWeibelK.Impact of a transition-of-care pharmacist during hospital discharge. J Am Pharm Assoc. 2015;55(4):443-448.
8.
NovakCJHastananSMoradiMTerryDF.Reducing unnecessary hospital readmissions: the pharmacist’s role in care transitions. Consult Pharm. 2012;27(3):174-179.
9.
HumeALKirwinJBieberHL, et al. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012;32(11):e326-e337.
10.
BackesAC.Lessons learned from the implementation of two transitions of care programs. Inov Pharm. 2013;4(1):105.
11.
WalkerSALoJKCompaniS, et al. Identifying barriers to medication discharge counselling by pharmacists. Can J Hosp Pharm. 2014;67(3):203-212.
12.
CassanoA. Best Practices From the ASHP-APhA Medication Management in Care Transitions Initiative. American Society of Health-system Pharmacists, Bethesda, MD: American Pharmacists Association; 2013.
13.
WalkerPCJonesJNTMasonNA.An advanced pharmacy practice experience in transitional care. Am J Pharm Educ. 2010;74(2):20.
